CBUS Stock Summary and Trading Ideas (Cibus - Class A | NASDAQ:CBUS)

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Cibus - Class A trades on the NASDAQ stock market under the symbol CBUS.

As of March 14, 2025, CBUS stock price declined to $2.20 with 201,410 million shares trading.

CBUS has a market cap of $67.75 million. This is considered a Micro Cap stock.

Last quarter Cibus - Class A reported $2 million in Revenue and $.06 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.95.

The top ETF exchange traded funds that CBUS belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

CBUS has underperformed the market in the last year with a return of -88.4%, while the SPY ETF gained +11.0%. In the last 3 month period, CBUS fell short of the market, returning -46.1%, while SPY returned -6.5%. However, in the most recent 2 weeks CBUS has outperformed the stock market by returning +7.3%, while SPY returned -5.3%.

CBUS support price is $2.07 and resistance is $2.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBUS shares will trade within this expected range on the day.